Recombinant VEGFR2/CD309 antibody

Catalog No. ABIN7675980

The Human Monoclonal anti-VEGFR2/CD309 antibody has been validated for ELISA, FACS, Func, BLI and SPR. It is suitable to detect VEGFR2/CD309 in samples from Human.

Quick Overview for Recombinant VEGFR2/CD309 antibody (ABIN7675980)

Target: VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This VEGFR2/CD309 antibody is un-conjugated

Application: ELISA, Flow Cytometry (FACS), Functional Studies (Func), Bio-Layer Interferometry (BLI), Surface Plasmon Resonance (SPR)

Product Details anti-VEGFR2/CD309 Antibody

Expression System: CHO Cells

Purpose: Anti-VEGFR2 / KDR / CD309 Reference Antibody (Imclone 6.64)

Characteristics: Anti-VEGFR2 / KDR / CD309 Reference Antibody (Imclone 6.64) is expressed from CHO. The heavy chain type is muIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for VEGFR2/CD309

Target: VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Alternative Name: VEGFR2

Molecular Weight: 145.5 kDa

UniProt: P35968

Pathways: RTK Signaling, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling